Suppr超能文献

血流动力学分类随时间的变化在系统性硬化症相关肺动脉高压中很常见:来自PHAROS队列的见解。

Changes in hemodynamic classification over time are common in systemic sclerosis-associated pulmonary hypertension: insights from the PHAROS cohort.

作者信息

Lammi Matthew R, Saketkoo Lesley Ann, Gordon Jessica K, Steen Virginia D

机构信息

1 Lousiana State University Health Sciences Center, New Orleans, LA, USA.

2 12255 Comprehensive Pulmonary Hypertension Center-University Medical Center New Orleans, New Orleans, LA, USA.

出版信息

Pulm Circ. 2018 Apr-Jun;8(2):2045893218757404. doi: 10.1177/2045893218757404.

Abstract

Group classification of pulmonary hypertension (PH) is based on pulmonary artery wedge pressure (PAWP) on right heart catheterization (RHC). How hemodynamics, particularly PAWP, change over time in systemic sclerosis (SSc)-PH patients is unknown. SSc-PH patients enrolled in the prospective observational PHAROS registry who had > 1 RHC (n = 120) were included in this analysis. Patients were considered to have a "PAWP class change" if they had a PAWP ≤ 15 mmHg on RHC-1 and then a PAWP > 15 on RHC-2 or had a PAWP > 15 on RHC-1 and then PAWP ≤ 15 on RHC-2. There was a median time of 1.4 years between RHC-1 and RHC-2 and 75% of patients had a PH medication added after their initial RHC. PAWP increased significantly (11 ± 5 versus 13 ± 6 mmHg, P = 0.01) between RHC-1 and RHC-2, particularly for patients who were started on PH medications. Overall, 30% of patients who had a repeat RHC experienced a PAWP class change between their initial and follow-up RHC, independent of whether a PH medication was added. Patients initially classified as World Health Organization group 2 PH were most likely to change PAWP class over time. In conclusion, PAWP values commonly change to a significant degree in SSc-PH, which highlights the challenges in using a single time-point PAWP to define clinical classification groups.

摘要

肺动脉高压(PH)的分组是基于右心导管检查(RHC)时的肺动脉楔压(PAWP)。目前尚不清楚在系统性硬化症(SSc)相关性PH患者中,血流动力学,尤其是PAWP,随时间如何变化。本分析纳入了前瞻性观察性PHAROS注册研究中接受过1次以上RHC检查的SSc-PH患者(n = 120)。如果患者在RHC-1时PAWP≤15 mmHg,而在RHC-2时PAWP>15 mmHg,或者在RHC-1时PAWP>15 mmHg,而在RHC-2时PAWP≤15 mmHg,则认为患者发生了“PAWP类别改变”。RHC-1和RHC-2之间的中位时间为1.4年,75%的患者在首次RHC检查后添加了PH药物。RHC-1和RHC-2之间PAWP显著升高(11±5与13±6 mmHg,P = 0.01),尤其是开始使用PH药物的患者。总体而言,30%接受重复RHC检查的患者在初始和随访RHC之间经历了PAWP类别改变,这与是否添加PH药物无关。最初被归类为世界卫生组织第2组PH的患者随着时间推移最有可能改变PAWP类别。总之,在SSc-PH中,PAWP值通常会发生显著变化,这凸显了使用单个时间点的PAWP来定义临床分类组所面临的挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fadb/5826006/5f266273e8be/10.1177_2045893218757404-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验